General Archives - Page 84 of 2367

2 minute read

Microsoft Launches Team Copilot To Boost Workplace Collaboration

May 21, 2:42 PM

Microsoft Corp. (NASDAQ: MSFT) unveiled Team Copilot, an AI assistant designed to enhance team collaboration by taking notes, summarizing key points, and managing deadlines. This launch, part of Microsoft's broader AI strategy, was announced at the annual Build conference. Team Copilot will be available to corporate clients later this year, reinforcing Microsoft's leadership in integrating AI into its productivity tools and cloud services.

AMD

2 minute read

Larimar Therapeutics’ Friedreich’s Ataxia Investigational Drug Differentiated From Biogen’s Marketed Drug

By Vandana Singh

May 21, 2:39 PM

Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data from Phase 2 study shows well-tolerated treatment with significant frataxin level increases.

BIIB

2 minute read

What’s Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?

By Vandana Singh

May 21, 2:36 PM

FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC detection and compliance, potentially extending patient survival.

1 minute read

Apparel Company VF’s Fortune Will Not Turn For The Better, Says Analyst

By Shivani Kumaresan

May 21, 2:28 PM

Wedbush analyst Tom Nikic reiterated a Neutral rating on VF Corp shares, lowering the price target from $15.5 to $13. Nikic's checks suggest continued business challenges, with Vans being a significant issue. The analyst cut FY24-26 EPS forecasts and noted declining e-commerce traffic for The North Face and Vans. The company's highly-levered balance sheet adds further pressure.

VFC

2 minute read

Weight Loss Drugs Like Wegvoy and Zepbound Users – Nestlé Launches $5 Pizza For You

By Vandana Singh

May 21, 2:25 PM

Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.

LLY

2 minute read

Citius Pharma’s ‘Antibiotic Lock’ Effective In Patients With Catheter-Associated Bloodstream Infections

By Vandana Singh

May 21, 1:40 PM

Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall treatment success.

CTXR

1 minute read

Nutanix Inks Pact With Dell & Nvidia – What’s Going On?

By Nabaparna Bhattacharya

May 21, 1:34 PM

Nutanix collaborates with Dell and Nvidia to deliver new joint solutions, enhancing cloud platform accessibility and AI capabilities.

DELL

2 minute read

What’s Going On With Mining Giant BHP Stock Tuesday?

By Nabaparna Bhattacharya

May 21, 1:08 PM

BHP Group hits a three-month high ahead of the Anglo bid deadline, amid positive market sentiments and speculation on acquisition discipline.

AAUKF

1 minute read

Shell Shareholders Reject Activist Climate Resolution: Details

By Shivani Kumaresan

May 21, 12:57 PM

Shell PLC (NYSE:SHEL) shareholders rejected a climate resolution by activist group Follow This, which aimed to align Shell's carbon targets with the Paris Agreement. Supported by investors managing $4 trillion, the proposal received 18.6% backing, down from last year's 20%. CEO Wael Sawan viewed the result as a vote of confidence in Shell's energy transition strategy, despite ongoing scrutiny and a significant legal challenge from a 2021 Dutch court ruling. Excerpt 2:

HAP

2 minute read

GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims

By Vandana Singh

May 21, 12:48 PM

Valisure sues GSK accusing the company of hiding cancer risks linked to Zantac, potentially defrauding the U.S. government. This follows Valisure's 2019 tests showing Zantac forms a carcinogen, prompting a whistleblower lawsuit seeking billions in damages.

GSK